The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Data Coordinating Center
This grant supports a center to coordinate genetic research, data, and biospecimen management for improving diagnosis and treatment of inflammatory bowel disease through the NIDDK IBD Genetics Consortium.
Funder: National Institutes of Health (NIH)
Due Dates: November 1, 2026 (forecasted)
Funding Amounts: Estimated total funding: $1,600,000 | Expected awards: 1 | Cooperative Agreement
Summary: Supports a Data Coordinating Center to advance collaborative genetic research and data management for the Inflammatory Bowel Disease Genetics Consortium (IBDGC).
Key Information: This is a forecasted opportunity; all dates are estimated and subject to change.
Description
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the NIH, is continuing its support for the Inflammatory Bowel Disease Genetics Consortium (IBDGC) through a dedicated Data Coordinating Center (DCC). The IBDGC has played a leading role in identifying over 300 genetic risk loci for various IBD subtypes and furthering understanding of disease mechanisms. Despite these advances, IBD remains a chronic, heterogeneous disease with no cure, and there is an ongoing need for improved biomarkers and predictors of disease outcomes.
The DCC will:
- Coordinate collaboration among IBDGC Genetic Research Centers, external scientific partners, and pilot projects.
- Oversee participant enrollment, biospecimen collection and processing.
- Manage submission of data and samples to central databases and repositories.
- Leverage patient cohorts, biospecimens, and advances in data science to characterize the interactions of genetic, clinical, and environmental factors in IBD.
- Develop new predictors of disease outcomes to improve medical management and advance precision medicine for IBD patients.
